Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERMES: Everolimus Conversion in Renal Transplant
NCT01269684Phase 4Withdrawn
- Sponsor
- Novartis
- Start
- Aug 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in kidney transplantation, sponsored by Novartis. Planned start Aug 2008; status: withdrawn.
02
Drugs
everolimus
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01269684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01269684.